Table of contents


On 29 October 2007, orphan designation (EU/3/07/490) was granted by the European Commission to Bone Therapeutics SA, Belgium, for human autologous bone-forming cells derived from bone marrow stem cells for treatment of non-traumatic osteonecrosis.

Please note that this product was withdrawn from the Union Register of orphan medicinal products in November 2019 on request of the Sponsor.

Key facts

Active substance
Human autologous bone-forming cells derived from bone marrow stem cells
Disease / condition
Treatment of non-traumatic osteonecrosis
Date of first decision
EU designation number

Sponsor's contact details

Bone Therapeutics SA
Rue Auguste Piccard 37
6041 Gosselies
Tel. +32 2 529 59 90
Fax +32 2 529 59 93

Patients' organisations

For contact details of patients’ organisations whose activities are targeted at rare diseases, see:

  • European Organisation for Rare Diseases (EURORDIS), a non-governmental alliance of patient organisations and individuals active in the field of rare diseases.

  • Orphanet, a database containing information on rare diseases, which includes a directory of patients’ organisations registered in Europe.

How useful was this page?

Add your rating